264 related articles for article (PubMed ID: 25204360)
1. Treatment options for second-stage gambiense human African trypanosomiasis.
Eperon G; Balasegaram M; Potet J; Mowbray C; Valverde O; Chappuis F
Expert Rev Anti Infect Ther; 2014 Nov; 12(11):1407-17. PubMed ID: 25204360
[TBL] [Abstract][Full Text] [Related]
2. Nifurtimox-eflornithine combination therapy for second-stage African Trypanosoma brucei gambiense trypanosomiasis: a multicentre, randomised, phase III, non-inferiority trial.
Priotto G; Kasparian S; Mutombo W; Ngouama D; Ghorashian S; Arnold U; Ghabri S; Baudin E; Buard V; Kazadi-Kyanza S; Ilunga M; Mutangala W; Pohlig G; Schmid C; Karunakara U; Torreele E; Kande V
Lancet; 2009 Jul; 374(9683):56-64. PubMed ID: 19559476
[TBL] [Abstract][Full Text] [Related]
3. Oral fexinidazole for late-stage African Trypanosoma brucei gambiense trypanosomiasis: a pivotal multicentre, randomised, non-inferiority trial.
Mesu VKBK; Kalonji WM; Bardonneau C; Mordt OV; Blesson S; Simon F; Delhomme S; Bernhard S; Kuziena W; Lubaki JF; Vuvu SL; Ngima PN; Mbembo HM; Ilunga M; Bonama AK; Heradi JA; Solomo JLL; Mandula G; Badibabi LK; Dama FR; Lukula PK; Tete DN; Lumbala C; Scherrer B; Strub-Wourgaft N; Tarral A
Lancet; 2018 Jan; 391(10116):144-154. PubMed ID: 29113731
[TBL] [Abstract][Full Text] [Related]
4. A multicentre, randomised, non-inferiority clinical trial comparing a nifurtimox-eflornithine combination to standard eflornithine monotherapy for late stage Trypanosoma brucei gambiense human African trypanosomiasis in Uganda.
Kansiime F; Adibaku S; Wamboga C; Idi F; Kato CD; Yamuah L; Vaillant M; Kioy D; Olliaro P; Matovu E
Parasit Vectors; 2018 Feb; 11(1):105. PubMed ID: 29471865
[TBL] [Abstract][Full Text] [Related]
5. Nifurtimox-eflornithine combination therapy for second-stage Trypanosoma brucei gambiense sleeping sickness: a randomized clinical trial in Congo.
Priotto G; Kasparian S; Ngouama D; Ghorashian S; Arnold U; Ghabri S; Karunakara U
Clin Infect Dis; 2007 Dec; 45(11):1435-42. PubMed ID: 17990225
[TBL] [Abstract][Full Text] [Related]
6. Human African Trypanosomiasis in Emigrant Returning to China from Gabon, 2017.
Wang X; Ruan Q; Xu B; Gu J; Qian Y; Chen M; Liu Q; Lu Q; Zhang W
Emerg Infect Dis; 2018 Feb; 24(2):400-404. PubMed ID: 29350158
[TBL] [Abstract][Full Text] [Related]
7. In-hospital safety in field conditions of nifurtimox eflornithine combination therapy (NECT) for T. b. gambiense sleeping sickness.
Schmid C; Kuemmerle A; Blum J; Ghabri S; Kande V; Mutombo W; Ilunga M; Lumpungu I; Mutanda S; Nganzobo P; Tete D; Mubwa N; Kisala M; Blesson S; Mordt OV
PLoS Negl Trop Dis; 2012; 6(11):e1920. PubMed ID: 23209861
[TBL] [Abstract][Full Text] [Related]
8. Population Pharmacodynamic Modeling of Eflornithine-Based Treatments Against Late-Stage Gambiense Human African Trypanosomiasis and Efficacy Predictions of L-eflornithine-Based Therapy.
Amilon C; Boberg M; Tarning J; Äbelö A; Ashton M; Jansson-Löfmark R
AAPS J; 2022 Mar; 24(3):48. PubMed ID: 35338410
[TBL] [Abstract][Full Text] [Related]
9. Prescription of concomitant medications in patients treated with Nifurtimox Eflornithine Combination Therapy (NECT) for T.b. gambiense second stage sleeping sickness in the Democratic Republic of the Congo.
Kuemmerle A; Schmid C; Kande V; Mutombo W; Ilunga M; Lumpungu I; Mutanda S; Nganzobo P; Ngolo D; Kisala M; Valverde Mordt O
PLoS Negl Trop Dis; 2020 Jan; 14(1):e0008028. PubMed ID: 31986140
[TBL] [Abstract][Full Text] [Related]
10. Chemotherapy for second-stage human African trypanosomiasis.
Lutje V; Seixas J; Kennedy A
Cochrane Database Syst Rev; 2013 Jun; 2013(6):CD006201. PubMed ID: 23807762
[TBL] [Abstract][Full Text] [Related]
11. Chemotherapy for second-stage Human African trypanosomiasis.
Lutje V; Seixas J; Kennedy A
Cochrane Database Syst Rev; 2010 Aug; (8):CD006201. PubMed ID: 20687080
[TBL] [Abstract][Full Text] [Related]
12. Chemotherapy for second-stage human African trypanosomiasis: drugs in use.
Lutje V; Probyn K; Seixas J; Bergman H; Villanueva G
Cochrane Database Syst Rev; 2021 Dec; 12(12):CD015374. PubMed ID: 34882307
[TBL] [Abstract][Full Text] [Related]
13. Effectiveness of Nifurtimox Eflornithine Combination Therapy (NECT) in T. b. gambiense second stage sleeping sickness patients in the Democratic Republic of Congo: Report from a field study.
Kuemmerle A; Schmid C; Bernhard S; Kande V; Mutombo W; Ilunga M; Lumpungu I; Mutanda S; Nganzobo P; Tete DN; Kisala M; Burri C; Blesson S; Valverde Mordt O
PLoS Negl Trop Dis; 2021 Nov; 15(11):e0009903. PubMed ID: 34748572
[TBL] [Abstract][Full Text] [Related]
14. The evolving spectrum of human African trypanosomiasis.
Kennedy PGE
QJM; 2024 Jun; 117(6):391-395. PubMed ID: 38065835
[TBL] [Abstract][Full Text] [Related]
15. NECT trial: more than a small victory over sleeping sickness.
Opigo J; Woodrow C
Lancet; 2009 Jul; 374(9683):7-9. PubMed ID: 19559477
[No Abstract] [Full Text] [Related]
16. Equivalence trial of melarsoprol and nifurtimox monotherapy and combination therapy for the treatment of second-stage Trypanosoma brucei gambiense sleeping sickness.
Bisser S; N'Siesi FX; Lejon V; Preux PM; Van Nieuwenhove S; Miaka Mia Bilenge C; Būscher P
J Infect Dis; 2007 Feb; 195(3):322-9. PubMed ID: 17205469
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and Toxicity of Fexinidazole and Nifurtimox Plus Eflornithine in the Treatment of African Trypanosomiasis: A Systematic Review.
Hidalgo J; Ortiz JF; Fabara SP; Eissa-Garcés A; Reddy D; Collins KD; Tirupathi R
Cureus; 2021 Aug; 13(8):e16881. PubMed ID: 34513456
[TBL] [Abstract][Full Text] [Related]
18. The continuing problem of human African trypanosomiasis (sleeping sickness).
Kennedy PG
Ann Neurol; 2008 Aug; 64(2):116-26. PubMed ID: 18756506
[TBL] [Abstract][Full Text] [Related]
19. Treatment of human African trypanosomiasis--present situation and needs for research and development.
Legros D; Ollivier G; Gastellu-Etchegorry M; Paquet C; Burri C; Jannin J; Büscher P
Lancet Infect Dis; 2002 Jul; 2(7):437-40. PubMed ID: 12127356
[TBL] [Abstract][Full Text] [Related]
20. Fexinidazole for the treatment of human African trypanosomiasis.
Fairlamb AH
Drugs Today (Barc); 2019 Nov; 55(11):705-712. PubMed ID: 31840685
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
